Gavin MacBeath insider trades

Open-market stock purchases and sales by Gavin MacBeath, Chief Executive Officer at TScan Therapeutics, Inc, from SEC Form 4 filings since Sep 20, 2021.

Track record: 0% of 2 scored buys are up 5% or more since purchase, averaging -97%.

Recent trades

DateStockTradeValue
Oct 1, 2026TCRX TScan Therapeutics, IncBought (not open market)—
Jan 20, 2026TCRX TScan Therapeutics, IncBought (not open market)—

Companies traded

  • TCRX TScan Therapeutics, Inc: 2 buys, last Oct 1, 2026

Get free alerts when Gavin MacBeath files a new trade →